Pacira BioSciences (PCRX) Retained Earnings (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Retained Earnings of -$196.4 million for Q1 2026, down 119.18% year-over-year from $1.0 billion in Q1 2025, and down 118.45% quarter-over-quarter from $1.1 billion in Q4 2025.
Pacira BioSciences (PCRX) Retained Earnings (2010 - 2026) Analysis & Trends
Pacira BioSciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$196.4 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 119.18% year-over-year to -$196.4 million; the TTM figure through Mar 2026 stood at -$196.4 million (down 119.18% YoY), while the FY2025 annual figure was $1.1 billion, up 310285.71% from the prior year.
- Retained Earnings for Q1 2026 stood at -$196.4 million, down from $1.1 billion in the prior quarter.
- The five-year high for Retained Earnings was $1.1 billion in Q4 2025, with the low at -$201.0 million in Q3 2025.
- The 5-year median for Retained Earnings is $105000.0 (2024), against an average of $250.6 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 722567.15% in 2024, then slumped 29739.97% in 2025.
- Pacira BioSciences' Retained Earnings stood at -$380000.0 in 2022, then soared by 257108.68% to $976.6 million in 2023, then slumped by 99.96% to $343000.0 in 2024, then soared by 310285.71% to $1.1 billion in 2025, then plunged by 118.45% to -$196.4 million in 2026.
- Business Quant data shows PCRX's Retained Earnings at -$196.4 million in Q1 2026, $1.1 billion in Q4 2025, and -$201.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | Pacira BioSciences | 945.31 Mn | 694.28 Mn | 148.24 Mn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Bn |
| Mar 31, 2026 | -196.41 Mn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | -200.96 Mn |
| Jun 30, 2025 | 4.06 Mn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 343,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 989.78 Mn |
| Dec 31, 2023 | 976.63 Mn |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -173,000.00 |
| Mar 31, 2023 | -137,000.00 |
| Dec 31, 2022 | -380,000.00 |
| Sep 30, 2022 | -138.65 Mn |
| Jun 30, 2022 | 895.15 Mn |
| Mar 31, 2022 | -157.83 Mn |
| Dec 31, 2021 | 942.09 Mn |
| Sep 30, 2021 | -206.77 Mn |